Lack of synergistic interaction between quercetin and catechin in systemic and pulmonary vascular smooth muscle

British Journal of Nutrition

Volumn 105, Issue 9, 2011, Pages 1287-1293

  Menendez, Carmen ^a,b   Jimenez, Rosario ^c   Moreno, Laura ^a,b   Galindo, Pilar ^c   Cogolludo, Angel ^a,b   Duarte, Juan ^c   Perez Vizcaino, Francisco ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Quercetin: Catechin: Isobologram: Endothelium

Indexed keywords

CATECHIN; QUERCETIN;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CELL CULTURE; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; ENDOTHELIAL DYSFUNCTION; IN VITRO STUDY; LUNG BLOOD VESSEL; MALE; MESENTERIC ARTERY; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; PULMONARY ARTERY; RAT; SYSTEMIC CIRCULATION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; AORTA; CATECHIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; PULMONARY ARTERY; QUERCETIN; RATS; RATS, WISTAR; SUPEROXIDES; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

RATTUS;

EID: 79956042288     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510004952     Document Type: Article

References (30)

1. Hertog MG, Feskens EJ, Hollman PC, et al. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342, 1007-1011. (Pubitemid 23314801)
2. Sampson L, Rimm E, Hollman PC, et al. (2002) Flavonol and flavone intakes in US health professionals. J Am Diet Assoc 102, 1414-1420. (Pubitemid 40445675)
3. Manach C, Scalbert A, Morand C, et al. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727-747. (Pubitemid 41103873)
4. Perez-Vizcaino F, Bishop-Bailley D, Lodi F, et al. (2006) The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells. Biochem Biophys Res Commun 346, 919-925. (Pubitemid 44192515)
5. Perez-Vizcaino F, Duarte J & Andriantsitohaina R (2006) Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic Res 40, 1054-1065. (Pubitemid 44480546)
6. Perez-Vizcaino F, Duarte J, Jimenez R, et al. (2009) Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 61, 67-75.
7. Loke WM, Proudfoot JM, Hodgson JM, et al. (2010) Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol 30, 749-757.
8. Duarte J, Perez Vizcaino F, Utrilla P, et al. (1993) Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure- activity relationships. Gen Pharmacol 24, 857-862. (Pubitemid 23231766)
9. Ibarra M, Perez-Vizcaino F, Cogolludo A, et al. (2002) Cardiovascular effects of isorhamnetin and quercetin in isolated rat and porcine vascular smooth muscle and isolated rat atria. Planta Med 68, 307-310. (Pubitemid 34494039)
10. Duarte J, Perez-Palencia R, Vargas F, et al. (2001) Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 133, 117-124. (Pubitemid 32500458)
11. Ihm SH, Lee JO, Kim SJ, et al. (2009) Catechin prevents endothelial dysfunction in the prediabetic stage of OLETF rats by reducing vascular NADPH oxidase activity and expression. Atherosclerosis 206, 47-53.
12. Pignatelli P, Pulcinelli FM, Celestini A, et al. (2000) The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr 72, 1150-1155.
13. Pignatelli P, Di Santo S, Buchetti B, et al. (2006) Polyphenols enhance platelet nitric oxide by inhibiting protein kinase C-dependent NADPH oxidase activation: effect on platelet recruitment. FASEB J 20, 1082-1089. (Pubitemid 44943904)
14. Silberberg M, Morand C, Manach C, et al. (2005) Coadministration of quercetin and catechin in rats alters their absorption but not their metabolism. Life Sci 77, 3156-3167. (Pubitemid 41433317)
15. Lopez-Lopez G, Moreno L, Cogolludo A, et al. (2004) Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. Mol Pharmacol 65, 851-859. (Pubitemid 38420490)
16. Jimenez R, Andriambeloson E, Duarte J, et al. (1999) Involvement of thromboxane A2 in the endothelium-dependent contractions induced by myricetin in rat isolated aorta. Br J Pharmacol 127, 1539-1544. (Pubitemid 29368985)
17. Cogolludo A, Moreno L, Frazziano G, et al. (2009) Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction. Cardiovasc Res 82, 296-302.
18. Lodi F, Jimenez R, Moreno L, et al. (2008) Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis 204, 34-39.
19. Perez-Vizcaino F, Cogolludo AL, Zaragoza-Arnaez F, et al. (1999) Vasodilator effects of sodium nitroprusside, levcromakalim and their combination in isolated rat aorta. Br J Pharmacol 128, 1419-1426.
20. Tallarida RJ (2001) Drug synergism: its detection and applications. J Pharmacol Exp Ther 298, 865-872. (Pubitemid 32761897)
21. Perez-Vizcaino F, Ibarra M, Cogolludo AL, et al. (2002) Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. J Pharmacol Exp Ther 302, 66-72. (Pubitemid 34680422)
22. Lam CS, Borlaug BA, Kane GC, et al. (2009) Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation 119, 2663-2670.
23. Sanchez M, Lodi F, Vera R, et al. (2007) Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide production, and overexpression of p47phox induced by angiotensin II in rat aorta. J Nutr 137, 910-915. (Pubitemid 46596886)
24. Sanchez M, Galisteo M, Vera R, et al. (2006) Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 24, 75-84. (Pubitemid 41818091)
25. Halliwell B (2008) Are polyphenols antioxidants or prooxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys 476, 107-112.
26. Cogolludo A, Frazziano G, Briones AM, et al. (2007) The dietary flavonoid quercetin activates BKCa currents in coronary arteries via production of H2O2. Role in vasodilatation. Cardiovasc Res 73, 424-431. (Pubitemid 44937694)
27. Cirico TL & Omaye ST (2006) Additive or synergetic effects of phenolic compounds on human low density lipoprotein oxidation. Food Chem Toxicol 44, 510-516. (Pubitemid 43375127)
28. Manach C, Williamson G, Morand C, et al. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S-242S.
29. Lodi F, Jimenez R, Moreno L, et al. (2008) Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis 204, 34-39.
30. Bieger J, Cermak R, Blank R, et al. (2008) Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 138, 1417-1420.